Archive: 2026/06

Natco Pharma Clears Key Hurdle in ZAR 4B Adcock Ingram Bid

Natco Pharma clears key shareholder hurdle in ZAR 4B bid for 35.75% stake in Adcock Ingram. The deal marks a strategic entry into South Africa's pharma market, with Bidvest retaining majority control.